We are live on ! Find out more
HCA icon

HCA Healthcare

564 hedge funds and large institutions have $22.6B invested in HCA Healthcare in 2017 Q4 according to their latest regulatory filings, with 99 funds opening new positions, 151 increasing their positions, 242 reducing their positions, and 57 closing their positions.

New
Increased
Maintained
Reduced
Closed

74% more first-time investments, than exits

New positions opened: 99 | Existing positions closed: 57

11% more funds holding in top 10

Funds holding in top 10: 1921 (+2)

7% more funds holding

Funds holding: 529564 (+35)

5% more capital invested

Capital invested by funds: $21.5B → $22.6B (+$1.07B)

2.04% less ownership

Funds ownership: 74.79%72.75% (-2%)

38% less repeat investments, than reductions

Existing positions increased: 151 | Existing positions reduced: 242

43% less call options, than puts

Call options by funds: $243M | Put options by funds: $427M

Holders
564
Holders Change
+35
Holders Change %
+6.62%
% of All Funds
12.79%
Holding in Top 10
21
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+10.53%
% of All Funds
0.48%
New
99
Increased
151
Reduced
242
Closed
57
Calls
$243M
Puts
$427M
Net Calls
-$184M
Net Calls Change
-$110M
Name Holding Trade Value Shares
Change
Change in
Stake
Aviva
126
Aviva
United Kingdom
$14.1M -$1.95M -24,212 -13%
DA
127
DSC Advisors
Illinois
$14.1M -$4.66K -58 -0%
AC
128
Ascend Capital
California
$14.1M +$12.9M +160,371 New
GF
129
Gabelli Funds
New York
$14M -$2.41M -30,000 -16%
Zurich Cantonal Bank
130
Zurich Cantonal Bank
Switzerland
$13.9M -$1.19M -14,854 -9%
CHCM
131
Columbus Hill Capital Management
New Jersey
$13.7M -$771K -9,600 -6%
Citadel Advisors
132
Citadel Advisors
Florida
$13.6M +$12.4M +154,594 New
Janus Henderson Group
133
Janus Henderson Group
United Kingdom
$13.4M -$29.7M -370,005 -71%
HEIP
134
Hudson Edge Investment Partners
New Jersey
$13.3M -$2.46M -30,584 -17%
Axa
135
Axa
France
$13.2M -$7.06M -87,900 -37%
UBS Group
136
UBS Group
Switzerland
$13.2M -$4.95M -61,576 -29%
USAA
137
United Services Automobile Association
Texas
$12.3M -$1.69M -21,051 -13%
Natixis Advisors
138
Natixis Advisors
Massachusetts
$12M +$890K +11,084 +9%
AP
139
AHL Partners
United Kingdom
$12M +$672K +8,370 +7%
BTS
140
BB&T Securities
Virginia
$11.6M -$314K -3,911 -3%
CWG
141
C WorldWide Group
Denmark
$11.5M
DZ Bank
142
DZ Bank
Germany
$11.4M +$450K +5,602 +5%
PNC Financial Services Group
143
PNC Financial Services Group
Pennsylvania
$11.2M -$431K -5,367 -4%
Toronto Dominion Bank
144
Toronto Dominion Bank
Ontario, Canada
$11M +$1.01M +12,533 +11%
ARTA
145
A.R.T. Advisors
New York
$10.3M +$5.82M +72,500 +160%
CC
146
Cannell & Co
New York
$9.86M -$8.73M -108,702 -49%
AIG
147
American International Group
New York
$9.79M +$136K +1,692 +2%
Thrivent Financial for Lutherans
148
Thrivent Financial for Lutherans
Minnesota
$9.48M -$6.67K -83 -0.1%
Millennium Management
149
Millennium Management
New York
$9.26M +$7.98M +99,325 +1,630%
BNP Paribas Financial Markets
150
BNP Paribas Financial Markets
France
$9.23M -$10.4M -129,233 -55%

HCA Hedge Fund Activity: Q4 2017 in Review

564 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q4 2017, worth a combined $22.6B — up 5% from $21.5B a quarter earlier.

Buyers outnumbered sellers: 99 funds opened new HCA positions and 57 closed out — a net gain of 42 holders — while 151 added to existing stakes and 242 trimmed.

The largest buyer was Magellan Asset Management, adding an estimated $376M. The largest seller was T. Rowe Price Associates, cutting an estimated $1.02B.

  • 564 institutional investors held HCA Healthcare (HCA) as of Q4 2017, up from 529 in Q3 2017.
  • Funds reported $22.6B of HCA Healthcare stock for Q4 2017, up 5% quarter-over-quarter.
  • 99 funds opened new HCA Healthcare positions in Q4 2017 and 57 closed out, a net change of +42 holders.
  • The largest HCA Healthcare buyer in Q4 2017 was Magellan Asset Management, an estimated $376M added.
  • The largest HCA Healthcare seller in Q4 2017 was T. Rowe Price Associates, an estimated $1.02B sold.

Based on aggregated 13F filings for Q4 2017.